Kessel D, Wilberding C
Cancer Treat Rep. 1985 Jun;69(6):673-6.
Studies were performed with the anthracycline-responsive P388 murine leukemia cell line, and with P388/ADR, a subline selected for doxorubicin resistance. In the P388/ADR cell line, the observed 100-fold daunorubicin resistance is associated with an outward drug transport system which can be inhibited by several calcium antagonists, eg, verapamil and nifedipine. An examination of compounds related to tiapamil, a verapamil analog, has identified a structure which is tenfold more effective than verapamil at potentiating anthracycline accumulation and responsiveness in P388/ADR cells. At no nontoxic level of any calcium antagonist examined was it possible to wholly reverse the degree of daunorubicin resistance found in the P388/ADR cell line.
研究使用了对蒽环类药物敏感的P388小鼠白血病细胞系,以及为多柔比星耐药性而选择的亚系P388/ADR。在P388/ADR细胞系中,观察到的柔红霉素100倍耐药性与一种外向药物转运系统有关,该系统可被几种钙拮抗剂抑制,例如维拉帕米和硝苯地平。对与维拉帕米类似物替帕米相关的化合物进行研究后,确定了一种结构,该结构在增强P388/ADR细胞中蒽环类药物的积累和反应性方面比维拉帕米有效10倍。在所检测的任何钙拮抗剂的无毒水平下,都不可能完全逆转P388/ADR细胞系中发现的柔红霉素耐药程度。